AffaMed Therapeutics (Acquired) is Drug Discovery in United States that focus on critical unmet business. Founded in 2019. They cover business area such as operator, transformative pharmaceutical product, critical unmet medical need, ophthalmology, neurological and psychiatric disorder, patient.
2019
( 5 years old in 2024 )
Critical Unmet
-
450 Lexington Avenue
Suite 39B
New York, NY 10017
United States
Private
operatortransformative pharmaceutical productcritical unmet medical needophthalmologyneurological and psychiatric disorderpatient
* We use standard office opening hours in near AffaMed Therapeutics (Acquired)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AffaMed Therapeutics (Acquired) is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), AffaMed Therapeutics (Acquired) business is focusing on Critical Unmet.
AffaMed Therapeutics (Acquired) headquarter office and corporate office address is located in 450 Lexington Avenue Suite 39B New York, NY 10017 United States.
AffaMed Therapeutics (Acquired) was founded in United States.
In 2024, AffaMed Therapeutics (Acquired) is currently focus on critical unmet sector.
Above is snippet of Google Trends for "critical unmet" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AffaMed Therapeutics (Acquired), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
